title: Candida albicans suppresses nitric oxide generation from macrophages via a secreted molecule.
abstract: Macrophages and neutrophils generate a potent burst of reactive oxygen and nitrogen species as a key aspect of the antimicrobial response. While most successful pathogens, including the fungus Candida albicans, encode enzymes for the detoxification of these compounds and repair of the resulting cellular damage, some species actively modulate immune function to suppress the generation of these toxic compounds. We report here that C. albicans actively inhibits macrophage production of nitric oxide (NO). NO production was blocked in a dose-dependent manner when live C. albicans were incubated with either cultured or bone marrow-derived mouse macrophages. While filamentous growth is a key virulence trait, yeast-locked fungal cells were still capable of dose-dependent NO suppression. C. albicans suppresses NO production from macrophages stimulated by exposure to IFN-γ and LPS or cells of the non-pathogenic Saccharomyces cerevisiae. The NO inhibitory activity was produced only when the fungal cells were in direct contact with macrophages, but the compound itself was secreted into the culture media. LPS/IFNγ stimulated macrophages cultured in cell-free conditioned media from co-cultures showed reduced levels of iNOS enzymatic activity and lower amounts of iNOS protein. Initial biochemical characterization of this activity indicates that the inhibitor is a small, aqueous, heat-stable compound. In summary, C. albicans actively blocks NO production by macrophages via a secreted mediator; these findings expand our understanding of phagocyte modulation by this important fungal pathogen and represent a potential target for intervention to enhance antifungal immune responses.
authors.affiliation: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
authors.forename: John R
authors.initials: JR
authors.lastname: Collette
authors.affiliation: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
authors.forename: Huaijin
authors.initials: H
authors.lastname: Zhou
authors.affiliation: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
authors.forename: Michael C
authors.initials: MC
authors.lastname: Lorenz
mesh_terms: D000818:Animals; D002176:Candida albicans / Q000502:physiology*; D002460:Cell Line; D018920:Coculture Techniques; D017077:Culture Media, Conditioned; D004794:Enzyme Repression; D015870:Gene Expression; D054884:Host-Pathogen Interactions; D007113:Immunity, Innate; D007371:Interferon-gamma / Q000502:physiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000201:enzymology* / Q000276:immunology; D051379:Mice; D009569:Nitric Oxide / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000276:immunology
chemical_list: D017077:Culture Media, Conditioned; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D007371:Interferon-gamma; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse
references.citation: J Biol Chem. 1992 Mar 25;267(9):6370-4
references.pmid: 1372907
references.citation: Infect Immun. 2011 Jun;79(6):2385-95
references.pmid: 21444664
references.citation: Infect Immun. 1995 Mar;63(3):1142-4
references.pmid: 7868241
references.citation: Genetics. 1993 Jul;134(3):717-28
references.pmid: 8349105
references.citation: J Infect Dis. 1995 Jul;172(1):192-8
references.pmid: 7541062
references.citation: Immunity. 1999 Jan;10(1):29-38
references.pmid: 10023768
references.citation: Infect Immun. 2001 Nov;69(11):6813-22
references.pmid: 11598054
references.citation: Cell Immunol. 1997 Aug 25;180(1):47-54
references.pmid: 9316638
references.citation: Mol Gen Genet. 1984;198(2):179-82
references.pmid: 6394964
references.citation: Cell Microbiol. 2009 Apr;11(4):560-89
references.pmid: 19134116
references.citation: Nature. 2001 Jul 5;412(6842):83-6
references.pmid: 11452311
references.citation: Br J Pharmacol. 1991 Jan;102(1):234-8
references.pmid: 1710525
references.citation: J Cell Biol. 1982 Apr;93(1):49-56
references.pmid: 6279673
references.citation: Acta Physiol Scand. 1999 Oct;167(2):145-50
references.pmid: 10571550
references.citation: Int J Med Microbiol. 2001 Mar;290(8):659-68
references.pmid: 11310444
references.citation: Microb Pathog. 2011 Feb;50(2):100-8
references.pmid: 21129481
references.citation: Eukaryot Cell. 2004 Oct;3(5):1076-87
references.pmid: 15470236
references.citation: Eukaryot Cell. 2004 Jun;3(3):715-23
references.pmid: 15189992
references.citation: Cell. 1997 Sep 5;90(5):939-49
references.pmid: 9298905
references.citation: Methods Enzymol. 1991;194:3-21
references.pmid: 2005794
references.citation: mBio. 2011 May 17;2(3):e00055-11
references.pmid: 21586647
references.citation: Clin Exp Immunol. 1999 Mar;115(3):491-7
references.pmid: 10193423
references.citation: PLoS Pathog. 2014 Mar 13;10(3):e1003995
references.pmid: 24626429
references.citation: Genetics. 1986 May;113(1):35-43
references.pmid: 3519363
references.citation: Br J Pharmacol. 1998 Dec;125(7):1511-6
references.pmid: 9884080
references.citation: Eukaryot Cell. 2005 Feb;4(2):298-309
references.pmid: 15701792
references.citation: Eukaryot Cell. 2013 Jan;12(1):91-100
references.pmid: 23143683
references.citation: Mol Microbiol. 2009 Jan;71(1):240-52
references.pmid: 19019164
references.citation: Mol Biol Cell. 2005 Oct;16(10):4814-26
references.pmid: 16030247
references.citation: Yeast. 1998 Jan 30;14(2):115-32
references.pmid: 9483801
references.citation: Microbiology (Reading). 1997 Feb;143 ( Pt 2):297-302
references.pmid: 9043106
references.citation: Nat Rev Microbiol. 2008 Jan;6(1):67-78
references.pmid: 18079743